From: IL-1 family cytokines and soluble receptors in systemic lupus erythematosus
Demographic features | Value | |
---|---|---|
Female/male ratio | 64/10 | |
Age at study (years), median (IQR) | 39.5 (30–50) | |
Disease duration (years), median (IQR) | 10 (4–20) | |
Disease activity (ECLAM), median (IQR) | 1.75 (0–3.1) | |
Clinical manifestations, percentage | Â | |
Arthralgia/arthritis | 44% | |
Haematological manifestations | 34% | |
Skin manifestations | 23% | |
Active nephritis | 23% | |
Nervous system involvement | 9% | |
Serositis | 5% | |
Serological features, percentage | Â | |
Complement | Low C3 levels | 63% |
Low C4 levels | 26% | |
Anti-DNA Ab | CLIF test | 46% |
ELISA | 49% | |
Anti-complement C1q Ab | 52% |